Finance Watch: Septerna Raises $288m In Public Market Debut
GPCR-Focused Firm Launches 23rd US IPO Of 2024
Public Company Edition: In addition to Septerna’s initial public offering, a new life science-focused SPAC went public. Also, Inventiva raised up to €348m ($376.2m), Akeso revealed a $250m private placement and Marinus is exploring strategic alternatives after a Phase III trial failure.